Synthesis 2012(5): 810-816  
DOI: 10.1055/s-0031-1289708
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

D 3-Trishomocubane-4-carboxylic Acid as a New Chiral Building Block: Synthesis and Absolute Configuration

Alexandr V. Gaidaia, Dmitriy M. Volochnyuk*b, Oleg V. Shishkinc, Andrey A. Fokina, Igor A. Levandovskiy*a, Tatyana E. Shubina*d
a Department of Organic Chemistry, Kiev Polytechnic Institute, Pr. Pobedy 37, 03056 Kiev, Ukraine
b Institute of Organic Chemistry, National Academy of Sciences of Ukraine, Murmanska 5, Kiev-94, 02094, Ukraine
Fax: +38(44)5024832; e-Mail: D.Volochnyuk@enamine.net;
c Division of Functional Materials Chemistry, SSI ‘Institute for Single Crystals’, National Academy of Science of Ukraine, Lenina ave. 60, Kharkiv 61001, Ukraine
d Computer-Chemie-Centrum and Interdisciplinary Center for Molecular Materials, University Erlangen-Nuremberg, Nagelsbachstr. 25, 91052 Erlangen, Germany
Fax: +49(9131)8526565; e-Mail: tatyana.shubina@chemie.uni-erlangen.de;
Weitere Informationen

Publikationsverlauf

Received 22 November 2011
Publikationsdatum:
15. Februar 2012 (online)

Abstract

The preparation of (±)-D 3-trishomocubanone on a multigram scale from 1,4-benzoquinone and cyclopentadiene was optimized to give the target product in 39% overall yield, that was transformed to (±)-D 3-trishomocubane-4-carboxylic acid via a three-step procedure involving the Corey-Chaykovsky reaction followed by boron trifluoride-diethyl ether catalyzed epoxide ring opening and further oxidation. Optically active (+)-D 3-trishomocubane-4-carboxylic acid was prepared through the resolution of the racemate by crystallization of its salt with (R)-phenylethylamine; the absolute configuration was assigned by X-ray crystal structure analysis.

    References

  • 1a Rogawski MA. Wenk GL. CNS Drugs Rev.  2003,  9:  275 
  • 1b Germane SK. Polis YY. Pharm. Chem. J.  1977,  11:  798 
  • 1c Berzinya DA. Kimenis AA. Exp. Clin. Farmacoterapia (in Russian)  1986,  15:  50 
  • 1d Krapivin SV. Sergeeva SA. Bull. Exp. Biol. Med.  1998,  125:  151 
  • 1e Kamianov I. Andrezinia RA. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova (in Russian)  1975,  75:  910 
  • 1f Liubimov BI. Skoldinov AP. Boíko SS. Farmakol. Toksikol. (Moscow) (in Russian)  1980,  43:  408 
  • 1g Petrenko ES. Ph.D. Thesis   State Foundation Institute of Pharmacology, Russian Academy of Medical Sciences; Moscow: 2003.  p.134 
  • 1h Boiko SS. Zherdev VP. Kisliak NA. Farmakol. Toksikol. (Moscow) (in Russian)  1991,  1991:  1 
  • 2a Morozov IS. Petrov VI. Sergeeva SA. The Pharmacology of Adamantanes (in Russian)   Volgograd State Medical Academy; Volgograd: 2001. 
  • 2b Kozeletskaia KN. Stotskaia LL. Serbin AV. Munshi K. Vopr. Virusol. (in Russian)  2003,  48:  19 
  • 2c Sevast’yanova VV. Krayushkin MM. Yurchenko AG. Russ. Chem. Rev. (Engl. Transl.)  1970,  39:  817 
  • 2d Litvinov VP. Chem. Heterocycl. Compd. (Engl. Transl.)  2002,  1:  9 
  • 2e Novakov IA. Orlinson BS. Polymer Science, Ser. C  2005,  47 (1):  50 
  • 3a Khardin AP. Radchenko SS. Russ. Chem. Rev. (Engl. Transl.)  1982,  51:  272 
  • 3b Hattori Y. Miyajima T. Sakai M. Nagase Y. Nemoto N. Polymer  2008,  49:  2825 
  • 4 Yang WL. Fabbri JD. Willey TM. Lee JRI. Dahl JE. Carlson RMK. Schreiner PR. Fokin AA. Tkachenko BA. Fokina NA. Meevasana W. Mannella N. Tanaka K. Zhou XJ. van Buuren T. Kelly MA. Hussain Z. Melosh NA. Shen ZX. Science (Washington, D.C.)  2007,  316:  1460 
  • 5 Underwood DG. Ramamoorthy B. Tetrahedron Lett.  1970,  11:  4125 
  • 6 Levandovsky IA. Sharapa DI. Cherenkova OA. Gaidai AV. Shubina TE. Russ. Chem. Rev. (Engl. Transl.)  2010,  79:  1005 ; and references therein
  • 7 Wang J. Ma C. Balannik V. Pinto LH. Lamb RA. DeGrado WF. ACS Med. Chem. Lett.  2011,  2:  307 
  • 8a Davies W. Grunert R. Haff R. McGahen J. Neumayer E. Paulshock M. Watts J. Wood T. Hermann E. Hoffman C. Science (Washington, D.C.)  1964,  144:  862 
  • 8b Staničova J. Miškovsky P. Šutiak V. Vet. Med. Czech.  2001,  46:  224 
  • 8c Gaiday AV. Levandovskiy IA. Byler KG. Shubina TE. Mechanism of Influenza a M2 Ion-Channel Inhibition: A Docking and QSAR Study, In Lecture Notes in Computer Science   Vol. 5102:  Bubak M. van Albada GD. Dongarra J. Sloot PMA. Springer; Berlin: 2008.  p.360-368  
  • 9 Kolocouris N. Kolocouris A. Foscolos GB. Fytas G. Neyts J. Padalko E. Balzarini J. Snoeck R. Andrei G. De Clercq E. J. Med. Chem.  1996,  39:  3307 
  • 10 Gaidai AV. Cherenkova OA. Levandovskiy IA. Shubina T. Russ. J. Org. Chem. (Engl. Transl.)  2010,  46:  769 
  • 11 Petrenko AE. Aleksandrov AM. Sorochinskii AE. Kukhar VP. Zh. Org. Khim. (in Russian)  1987,  23:  2248 
  • 12 Kent GJ. Godleski SA. Osawa E. Schleyer P.
    J. Org. Chem.  1977,  42:  3852 
  • 13 Cookson RC. Crundwell E. Hill RR. Hudec J. J. Chem. Soc.  1964,  3062 
  • 14 Mukherjee A. Wu Q. le Noble WJ. J. Org. Chem.  1994,  59:  3270 
  • 15 Toyota M. Yokota M. Ihara M. J. Am. Chem. Soc.  2001,  123:  1856 
  • 16 Bailey A, Mete A, Pairaudeau G, Stocks M, and Wenlock M. inventors; WO  2007/123465. 
  • 17 Comer WT. Temple DL. J. Org. Chem.  1973,  38:  2121 
  • 18a Corey EJ. Chaykovsky M. J. Am. Chem. Soc.  1962,  84:  866 
  • 18b Corey EJ. Chaykovsky M. J. Am. Chem. Soc.  1965,  87:  1345 
  • 19 Ciaccio JA. Drahus AL. Meis RM. Tingle CT. Smrtka M. Geneste R. Synth. Commun.  2003,  33:  2135 
  • 20 Eaton PE. Leipzig B. J. Org. Chem.  1978,  43:  2483 
  • 21 Helmchen G. Staiger G. Angew. Chem., Int. Ed. Engl.  1977,  16:  116 
  • 22 Sheldrick GM. Acta Crystallogr., Sect. A  2008,  64:  112 
  • 24 Smith EC. Barborak JC. J. Org. Chem.  1976,  41:  1433 
23

The final atomic coordinates, and crystallographic data for molecule (+)-18 have been deposited with the Cambridge Crystallographic Data Centre, 12 Union Road, CB2 1EZ, UK [fax: +44(1223)336033; e-mail: deposit@ccdc.cam.ac.uk, and are available on request quoting the deposition number CCDC 827046].